Last deal
Amount
Stage
Date
all rounds
Total amount
date founded
Financing round
General
About Company
Industry
Sector :
Subsector :
Keywords :
founded date
founders
Number of employees
Company Type
Last funding type
IPO status
Contacts
location
Contact Email
Phone number
Website URL
Similar Companies999
Asceneuron
Asceneuron is a biotech company that develops effective therapeutics for orphan tauopathies and Alzheimer's disease.
Sector
Subsector
Location
total rounds
total raised
Athira Pharma
Athira Pharma is a drug development company focused on advancing therapies for neurodegenerative diseases.
Sector
Subsector
Keywords
Location
total rounds
total raised
Arbele Corp.
Arbele develops affordable therapeutics for cancer, immune disorders, and neurological diseases.
Sector
Subsector
Keywords
Location
Tetra Therapeutics
Tetra Discovery Partners develops drugs for brain-related diseases.
Sector
Subsector
Keywords
Location
total rounds
total raised
Financials
Funding Rounds7
Number of Funding Rounds
Money Raised
Their latest funding was raised on 04.10.2018. Their latest investor POSCO BioVentures. Their latest round Venture - Series Unknown
Wilmar International
Wilmar International Limited is Asia's leading agribusiness group.
Sector
Subsector
Location
total rounds
total raised
count Of Investments
Co-Investors
Investors4
Number of lead investors
Number of investors
POSCO BioVentures
POSCO BioVentures is a VC investing in biotech companies.
Sector
Subsector
Location
count Of Investments
count Of Exists
Bloodstone Ventures
Bloodstone Ventures is a company that was established in 2013.
Sector
Subsector
count Of Investments
Inventages Venture Capital Investment Inc.
Inventages Venture Capital Investment Inc is a Nestle SA investment arm that specializes in venture investments.
Sector
Subsector
Location
count Of Investments
count Of Exists
People
Founders4
Samuel Henderson
Samuel Henderson's research has defined new pathways in the understanding of neurodegenerative diseases, such as Alzheimer's disease. Most recently, Dr. Henderson was at The Institute of Behavioral Genetics, University of Colorado, Boulder, CO where he investigated the genetics of aging. Prior to that, he was a Lead Scientist at GenoPlex, Inc. directing research in anti-aging technologies. Dr. Henderson has co-authored numerous scientific publications, patents and reviews, including fundamental discoveries in aging research. He received his B.A. in Biology from Washington University, St. Louis, MO and his Ph.D. in Molecular Genetics and Cell Biology from University of Chicago. He received extensive post-doctoral training in developmental biology at the University of Wisconsin. Dr. Henderson is the scientific founder of Accera.
current job
organization founded
Samuel Henderson
Mark Heiman
Mark Heiman is CSO at Scioto Biosciences.
current job
organization founded
Mark Heiman
Employee Profiles8
Samuel Henderson
Vice President, Research & Development